Cancer Stem Cell Therapeutics Market was valued at USD 658.5 Million in 2016, registering a CAGR of 10.5% over forecast period 2020-2026

The Global Cancer Stem Cell Therapeutics Market was valued at USD 658.5 Million in 2016, registering a CAGR of 10.5% over forecast period 2020-2026. Factors augmenting the growth include increase in transplantation procedures, high target disease prevalence, improved survival rate of patients, advantages of autologous transplant and affordability.

Cancer stem cells (CSCs) form a component of tumors that inherit the stem cell features such as differentiation, self-renewal and the potential to reiterate the native tumour when displaced into a host. Cancer stem cells are known to resist chemotherapy and hence result into a poor clinical outcome. On contrary, stem cells against cancer are used in transplantation of bone marrow that is inhibited by cancer cells by chemotherapy or radiation. In cancer forms such as myeloma and leukemias, a stem cell transplant forms an important part of treatment. A stem cell transplant between two people can result in treating for various type of cancers.

About DataIntelo:
DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info:
Name: Alex Mathews
Address: 500 East E Street, Ontario,
CA 91764, United States.
Phone No: USA: +1 909 545 6473 | IND: +91-7000061386
Email: [email protected]
Website: https://dataintelo.com